Comparison of characteristics and ventilatory course between coronavirus disease 2019 and Middle East respiratory syndrome patients with acute respiratory distress syndrome

다국어 초록 (Multilingual Abstract)

Background: Both coronavirus disease 2019 (COVID-19) and Middle East respiratory syndrome (MERS) can cause acute respiratory distress syndrome (ARDS); however, their ARDS course and characteristics have not been compared, which we evaluate in our study.
Methods: MERS patients with ARDS seen during the 2014 outbreak and COVID-19 patients with ARDS admitted between March and December 2020 in our hospital were included, and their clinical characteristics, ventilatory course, and outcomes were compared.
Results: Forty-nine and 14 patients met the inclusion criteria for ARDS in the COVID-19 and MERS groups, respectively. Both groups had a median of four comorbidities with high Charlson comorbidity index value of 5 points (P>0.22). COVID-19 patients were older, obese, had significantly higher initial C-reactive protein (CRP), more likely to get trial of high-flow oxygen, and had delayed intubation (P≤0.04). The postintubation course was similar between the groups. Patients in both groups experienced a prolonged duration of mechanical ventilation, and majority received paralytics, dialysis, and vasopressor agents (P>0.28). The respiratory and ventilatory parameters after intubation (including tidal volume, fraction of inspired oxygen, peak and plateau pressures) and their progression over 3 weeks were similar (P>0.05). Rates of mortality in the ICU (53% vs. 64%) and hospital (59% vs. 64%) among COVID-19 and MERS patients (P≥0.54) were very high.
Conclusions: Despite some distinctive differences between COVID-19 and MERS patients prior to intubation, the respiratory and ventilatory parameters postintubation were not different. The higher initial CRP level in COVID-19 patients may explain the steroid responsiveness in this population.

참고문헌 (Reference)

1 Stockman LJ, "SARS: systematic review of treatment effects" 3 : e34-, 2006

2 Ayaz Ahmed, "Risk factors for intensive care unit admission and mortality in hospitalized COVID-19 patients" 대한중환자의학회 35 (35): 249-254, 2020

3 Meduri GU, "Prolonged glucocorticoid treatment is associated with improved ARDS outcomes : analysis of individual patients’data from four randomized trials and trial-level meta-analysis of the updated literature" 42 : 829-840, 2016

4 Wong CK, "Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome" 136 : 95-103, 2004

5 Gralinski LE, "Molecular pathology of emerging coronavirus infections" 235 : 185-195, 2015

6 Zumla A, "Middle East respiratory syndrome" 386 : 995-1007, 2015

7 REMAP-CAP Investigators, "Interleukin-6 receptor antagonists in critically ill patients with Covid-19" 384 : 1491-1502, 2021

8 Pais FM, "Influence of clinical factors and exclusion criteria on mortality in ARDS observational studies and randomized controlled trials" 63 : 1060-1069, 2018

9 김은영, "Identification of risk factors for mortality in COVID-19 patients" 대한중환자의학회 35 (35): 296-297, 2020

10 Panadero C, "Highflow nasal cannula for acute respiratory distress syndrome(ARDS)due to COVID-19" 15 : 693-, 2020

11 Frat JP, "High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure" 372 : 2185-2196, 2015

12 Mellado-Artigas R, "High-flow nasal oxygen in patients with COVID-19-associated acute respiratory failure" 25 : 58-, 2021

13 Lyons PG, "Factors associated with clinical deterioration among patients hospitalized on the wards at a tertiary cancer hospital" 15 : e652-e665, 2019

14 Avinash Kumar Jha, "Evolution of COVID-19 management in critical care: review and perspective from a hospital in the United Kingdom" 대한중환자의학회 36 (36): 1-14, 2021

15 Burnham EL, "Detection of fibroproliferation by chest high-resolution CT scan in resolving ARDS" 146 : 1196-1204, 2014

16 Fajgenbaum DC, "Cytokine storm" 383 : 2255-2273, 2020

17 Arabi YM, "Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome" 197 : 757-767, 2018

18 Fadel Francois Abi, "Clinical characteristics and outcomes of critically Ill patients with COVID-19 in Northeast Ohio: low mortality and length of stay" 대한중환자의학회 35 (35): 242-248, 2020

19 COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators, "Clinical characteristics and day-90outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study" 47 : 60-73, 2021

20 Shaver CM, "Clinical and biological heterogeneity in acute respiratory distress syndrome : direct versus indirect lung injury" 35 : 639-653, 2014

21 Lal Tusharindra, "COVID-19 patients: when and whom to ventilate?" 대한중환자의학회 35 (35): 218-219, 2020

22 Gibson PG, "COVID-19 acute respiratory distress syndrome(ARDS) : clinical features and differences from typical pre-COVID-19 ARDS" 213 : 54-56, 2020

23 John S. Zorbas, "Airway pressure release ventilation in mechanically ventilated patients with COVID-19: a multicenter observational study" 대한중환자의학회 36 (36): 143-150, 2021

24 Li X, "Acute respiratory failure in COVID-19: is it “typical”ARDS?" 24 : 198-, 2020

25 ARDS Definition Task Force, "Acute respiratory distress syndrome: the Berlin Definition" 307 : 2526-2533, 2012

26 Lew TW, "Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome" 290 : 374-380, 2003

27 Khalid I, "Acute management and long-term survival among subjects with severe Middle East respiratory syndrome coronavirus pneumonia and ARDS" 61 : 340-348, 2016

28 Cockrell AS, "A mouse model for MERS coronavirus-induced acute respiratory distress syndrome" 2 : 16226-, 2016